High materiality8/10
X Xenon Pharmaceuticals price target lowered to $70 from $81 at RBC Capital
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
XENE target $70; posted price $40.28; RBC Capital.
- Target $70; price $40.28; RBC Capital
Key facts
- 01
Target: $70
- 02
Posted price: $40.28
- 03
Analyst firm: RBC Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.